Mechanistically, AE-EA and OLRF significantly suppressed mitogen-activated protein kinase (MAPK) signaling through inhibition of ERK1/2, JNK1/2, and p38 phosphorylation in both NSCLC cells (<i>p</i> < 0.05). The gene discussed is MAPK3; the disease is non-small cell lung carcinoma.